Tokyo, Jan. 5 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059706) titled 'Efficacy, Safety, and Biomarker Exploration of Mepolizumab Therapy for Postoperative Recurrent Eosinophilic Chronic Rhinosinusitis: A Prospective Multicenter Cohort Study' on Jan. 5.
Study Type:
Observational
Primary Sponsor:
Institute - Graduate School of Medicine, Kyoto University
Condition:
Condition - Postoperative Recurrent Eosinophilic Chronic Rhinosinusitis
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - This study prospectively investigates the clinical outcomes of mepolizumab treatment in patients with postoperative recurrent eosinophilic chronic rhinosinu...